10x Genomics TXG
NASDAQ TXG
$93.50 +4.74 (+5.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

10x Genomics (TXG) Return on Sales [ROS] (2018 - 2026)

Updated

10x Genomics (TXG) posted Return on Sales [ROS] of -12.95% for Q2 2026, down 30.37 percentage points from 17.42% a year earlier and down 1.65 percentage points from the prior quarter.

Analysis

10x Genomics (TXG) Return on Sales [ROS] (2018 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at 10x Genomics was -14.33%, up 1.27 percentage points year-over-year; for FY2025, it came in at -9.49%, up 22.37 percentage points from FY2024.

  • Annual Return on Sales [ROS] shows a five-year change of +169.25 percentage points (FY2020 to FY2025).
  • In prior years, 10x Genomics' Return on Sales [ROS] was -31.85% in FY2024 (+11.03 pp), -42.88% in FY2023 (-10.36 pp), -32.52% in FY2022 (-21.87 pp) and -10.65% in FY2021 (+168.08 pp).
  • Quarterly Return on Sales [ROS] has run from a low of -61.70% in Q3 2023 to a high of 17.42% in Q2 2025 over five years.
  • On a year-over-year basis, Return on Sales [ROS] increased in six of the last eight quarters, with an average year-over-year change of +13.11 percentage points.
  • The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q4 2021, with a gain of 353.96 percentage points; the weakest was Q2 2022, with a drop of 46.16 percentage points.
  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -11.30% (Q1 2026), -11.77% (Q4 2025) and -21.64% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn 13.44%
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 33.60%
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 18.08%
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn 25.18%
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 21.65%
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 29.48%
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn 13.31%
10 10x Genomics 12.18 Bn 11.98 Bn 112.50 Mn -12.95%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -12.95%
Mar 31, 2026 -11.30%
Dec 31, 2025 -11.77%
Sep 30, 2025 -21.64%
Jun 30, 2025 17.42%
Mar 31, 2025 -25.39%
Dec 31, 2024 -30.20%
Sep 30, 2024 -27.36%
Jun 30, 2024 -27.26%
Mar 31, 2024 -43.61%
Dec 31, 2023 -30.00%
Sep 30, 2023 -61.70%
Jun 30, 2023 -43.15%
Mar 31, 2023 -38.71%
Dec 31, 2022 -14.78%
Sep 30, 2022 -30.51%
Jun 30, 2022 -55.07%
Mar 31, 2022 -36.45%
Dec 31, 2021 -11.03%
Sep 30, 2021 -12.67%
API Access

10x Genomics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=TXG&period=max&api_key=YOUR_API_KEY